Nikang Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nikang Therapeutics's estimated annual revenue is currently $9.5M per year.(i)
  • Nikang Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Nikang Therapeutics has 61 Employees.(i)
  • Nikang Therapeutics grew their employee count by 27% last year.

Nikang Therapeutics's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
2
CSOReveal Email/Phone
3
SVP Clinical DevelopmentReveal Email/Phone
4
VP, Regulatory Affairs and Quality AssuranceReveal Email/Phone
5
VP Intellectual PropertyReveal Email/Phone
6
VP ChemistryReveal Email/Phone
7
VP CMCReveal Email/Phone
8
Director Cancer BiologyReveal Email/Phone
9
Executive Director, ControllerReveal Email/Phone
10
Director BiostatisticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$78.9M5090%N/AN/A
#2
$1.1M717%N/AN/A
#3
$1.7M11-8%N/AN/A
#4
$1.4M90%N/AN/A
#5
$6.7M4323%N/AN/A
#6
$0.8M50%N/AN/A
#7
$10.5M6824%N/AN/A
#8
$1.6M1011%N/AN/A
#9
$1.4M929%N/AN/A
#10
$43.9M28319%N/AN/A
Add Company

What Is Nikang Therapeutics?

NiKang Therapeutics, Inc. is a privately-held biotech company focused on developing novel small molecule oncology drug discovery. Their mission is to discover and develop first-in-class, and/or best-in-class small molecule targeted therapies and immuno-oncology (I-O) drugs to help cure cancers.

keywords:N/A

N/A

Total Funding

61

Number of Employees

$9.5M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nikang Therapeutics News

2022-03-30 - NiKang Therapeutics Presents Preclinical Data Highlighting ...

NiKang Therapeutics is a clinical stage biotech company focused on discovering and developing innovative small molecule oncology medicines...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.3M6117%N/A
#2
$14M6149%N/A
#3
$17.8M6149%N/A
#4
$9.6M615%N/A
#5
$7.1M61-3%N/A